Estimates Revisions PharmaEssentia Corporation
Stocks
6446
TW0006446008
Biotechnology & Medical Research
|
End-of-day quote
Taiwan S.E.
13/08/2026
|
5-day change | 1st Jan Change | ||
| 1,445.00 TWD | +0.35% |
|
+12.02% | +241.04% |
| 08-13 | PharmaEssentia Clarifies Report Projecting 2026 Revenue | MT |
| 08-12 | PharmaEssentia Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 6446 Stock
- Consensus PharmaEssentia Corporation
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
